Ashwagandha leaf derived withanone protects normal human cells against the toxicity of methoxyacetic acid, a major industrial metabolite.
The present day lifestyle heavily depends on industrial chemicals in the form of agriculture, cosmetics, textiles and medical products. Since the toxicity of the industrial chemicals has been a concern to human health, the need for alternative non-toxic natural products or adjuvants that serve as an...
Main Authors: | Didik Priyandoko, Tetsuro Ishii, Sunil C Kaul, Renu Wadhwa |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-05-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3087802?pdf=render |
Similar Items
-
Selective killing of cancer cells by Ashwagandha leaf extract and its component Withanone involves ROS signaling.
by: Nashi Widodo, et al.
Published: (2010-10-01) -
Ashwagandha derived withanone targets TPX2-Aurora A complex: computational and experimental evidence to its anticancer activity.
by: Abhinav Grover, et al.
Published: (2012-01-01) -
Protective role of Ashwagandha leaf extract and its component withanone on scopolamine-induced changes in the brain and brain-derived cells.
by: Arpita Konar, et al.
Published: (2011-01-01) -
Computational Insights into the Potential of Withaferin-A, Withanone and Caffeic Acid Phenethyl Ester for Treatment of Aberrant-EGFR Driven Lung Cancers
by: Vidhi Malik, et al.
Published: (2021-01-01) -
Combinations of Ashwagandha leaf extracts protect brain-derived cells against oxidative stress and induce differentiation.
by: Navjot Shah, et al.
Published: (2015-01-01)